Fluid retention should be considered, particularly in patients with heart failure, chronic kidney disease, or those experiencing peripheral oedema
The absence of a control group precludes definitive conclusions on causality between GLP-1 receptor agonist therapy and observed outcomes, and residual confounding cannot be excluded In conclusion, arGLP-1 represent a valuable addition to the therapeutic arsenal for managing IWL or WR after BS
Once reconstituted, always refrigerate and use within 46 weeks
Boxes are held in the Inter Express Logistics cold room temperature-monitored before dispatch
Some of the conditions being investigated include gastroparesis, ileus, necrotizing pancreatitis, vision loss, pulmonary embolism, and deep vein thrombosis
These are typically mild and include: Nausea/vomiting Digestive issues Abdominal discomfort Diarrhea or constipation Fatigue Heartburn Side effects of semaglutide typically decrease over time as your body adjusts to the medication, and we are mindful to prescribe dosage levels that minimize side effects